Autor: |
AL-Taie, A. F., Saloum, Warka'a T., Shabil, Forat Yahya Mohsin |
Předmět: |
|
Zdroj: |
Plant Archives (09725210); Oct2020, Vol. 20 Issue 2, p2841-2846, 6p |
Abstrakt: |
The third most ordinarily cancer type diagnosed in male and is Colorectal cancer (CRC) and it is widely spread in developed countries. Most of CRC arises from development of adenomatous polyps. The current study aimed to determine whether serum retinol binding protein 4 (RBP4) and Nesfatin-1 can be used as a novel biomarker for diagnosis of CRC. Nesfatin-1, RBP4 and Thyroid Hormones (T3, T4 and TSH) levels were measured in fifty sera of male patients suffering from CRC before chemotherapy initiation treatment as G1, G2 after first chemotherapy cycle dose and G3 after second chemotherapy cycle dose compared with twenty five male volunteers as a control G4. The results showed a significant increased in RBP 4 concentration in G3 and a significant elevated in nesfatin-1 in G2 than other groups. The correlation between RBP4 and TSH was a high significant negative (-ve) relation while with nesfatin-1 gave a significant positive (+ve) correlation in G1. The results also found significant positive (+ve) correlation between RBP-4 with, nesfatin-1 in G2 and there was significant negative (-ve) correlation between RBP4 with nesfatin-1 in G3. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|